📰 Ivir News
Page 9 - Ivir News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ivir. Real-time updates on events, politics, business and more.
June 9, 2023
Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its holdings in Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) by 17.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 81,205 shares of the company’s stock after buying an additional 12,321 shares during the […]
June 7, 2023
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 34,365 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $27.32, for a total value of $938,851.80. Following the transaction, the insider now directly owns 17,144,220 shares in the […]
June 7, 2023
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 5,197 shares of the business’s stock in a transaction on Monday, June 5th. The stock was sold at an average price of $27.32, for a total value of $141,982.04. Following the sale, the insider now owns 17,139,023 shares in the company, […]
June 2, 2023
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) Director Saira Ramasastry sold 3,500 shares of the business’s stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $25.67, for a total value of $89,845.00. Following the sale, the director now directly owns 10,619 shares of the company’s stock, valued […]
June 2, 2023
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) insider Steven J. Rice sold 2,500 shares of Vir Biotechnology stock in a transaction on Thursday, June 1st. The stock was sold at an average price of $25.67, for a total value of $64,175.00. Following the sale, the insider now directly owns 106,840 shares of the company’s stock, […]
June 1, 2023
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) gapped down before the market opened on Thursday . The stock had previously closed at $26.67, but opened at $25.67. Vir Biotechnology shares last traded at $25.89, with a volume of 100,878 shares trading hands. Analyst Ratings Changes VIR has been the topic of several research analyst reports. […]
May 30, 2023
Biopharmaceutical company Atea Pharmaceuticals, Inc. (AVIR) announced Tuesday that its Board of Directors unanimously rejected the unsolicited proposal from Tang Capital Partners, LP on behalf of Concentra Biosciences, LLC to acquire all outstanding common shares of Atea for $5.
May 26, 2023
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 104,384 shares of the firm’s stock in a transaction on Wednesday, May 24th. The shares were sold at an average price of $26.15, for a total transaction of $2,729,641.60. Following the completion of the transaction, the insider now owns 17,178,585 shares […]
May 25, 2023
UBS Group AG raised its stake in shares of Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) by 177.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 289,727 shares of the company’s stock after buying an additional 185,199 shares during the quarter. UBS Group […]
May 25, 2023
Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) gapped down prior to trading on Thursday . The stock had previously closed at $26.10, but opened at $25.31. Vir Biotechnology shares last traded at $25.99, with a volume of 43,800 shares trading hands. Analyst Ratings Changes A number of research analysts recently weighed in on the company. […]